Australia's largest stock trading and investment forum Australia's #1 stock forum

New Study Confirms Ivermectin Outperforms Other Options, page-2

First 2 Last

Share
Profile

Follow
Lomu

18,039 Posts.

37

14/02/22

17:11

Post #: 59562173
Share
Originally posted by Blackbean ↑

Researchers used computational analyses to evaluate the performance of 10 medications against the Omicron variant, finding that ivermectin outperformed all of them, including nirmatrelvir (Paxlovid) a new drug from Pfizer that has cost taxpayers $5.29 billion and costs $529 per course of treatment

Ivermectin lowers the viral load by inhibiting replication, reduces infection by 86% when used preventively, speeds recovery, protects against organ damage, lowers the risk of hospitalization and death and costs between $48 and $95 for a course of treatment depending on your location

Early treatment lowers your risk of long COVID, which includes physical and mental health conditions. According to cardiologist Dr. Peter McCullough, 50% of those sick enough to be hospitalized have symptoms of long COVID

Africa has a lower number of cases, severity of disease, hospitalizations and deaths than other areas of the world, which may be due to using prophylactic medications for endemic infections that have successfully treated COVID

https://articles.mercola.com/sites/...20220214&mid=DM1108841&rid=1407164044

Expand

You know Joseph Mercola has been busted for fraud multiple times don't you?
1 Upvote

Reply

Top Stories

THL

Tourism Holdings says Liberation Day tariffs smashed US RV demand

Trump chides Powell as Goldman call for calm. The RBA must be nervous

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming

I88

Infini Resources onto Phase 2 at Portland Creek after spotting 'widespread uranium'

NMG

New Murchison Gold blasts off at Crown Prince as 'better than expected' results return

First 2 Last

SPONSORED BY